Abstract:Background/aims Platelet glycoproteins play a crucial role in the initial stage of thrombus formation and may contribute to the pathophysiology of atherosclerosis. Polymorphisms in glycoprotein genes alter the function of the protein, possibly leading to increased risk of ischemic stroke. However, previous genetic association studies that examined the relationship between glycoprotein genes polymorphisms and ischemic stroke have yielded inconsistent results. This study aimed to evaluate the association between glycoprotein genes and ischemic stroke by the application of meta-analysis.Methods Relevant studies were identified by an extensive search through databases. The quality of included studies was assessed independently using the Newcastle-Ottawa Scale. Allele and genotype frequencies for each included study were extracted. The odds ratio (OR) with 95% confidence interval (95%CI) was calculated using a random-effects or fixed-effects model. Q statistic was used to evaluate homogeneity, and a meta-regression model was used to explore the study-level variables and to describe the heterogeneity in included studies. Egger's test and funnel plot were used to assess publication bias.Results A total of 60 studies (9 polymorphisms) were included and identified in the current meta-analysis. The Newcastle-Ottawa Scale scores ranged from 7 to 9 except for two studies with Newcastle-Ottawa Scale scores of 6. The T allele or TT genotype of the glycoprotein Ia C807T polymorphism were associated with an increased susceptibility to ischemic stroke in combined population (807T allele: OR, 95%CI: 1.24, 1.03-1.50, p=0.02) or Asian populations (807T allele: OR, 95%CI: 1.31, 1.10-1.54, p=0.002 and 807TT genotype: OR, 95%CI: 1.53, 1.13-2.08, p=0.006, respectively), and the Ser allele of HPA-3 was associated with increased risk of ischemic stroke in combined population or in Asians (OR, 95%CI: 1.21, 1.04-1.40, p=0.01 or 1.54, 1.18-2.01, p=0.001). Of note, the Ser/Ser genotype was more common in Asians (OR, 95%CI: 2.09, 1.40-3.13, p<0.001). For glycoprotein Ib variable number tandem repeat, only B allele showed a mild significant association with ischemic stroke risk in combined population or in Caucasians (OR, 95%CI: 2.17, 1.04-4.55, p=0.04 or 1.79, 1.02-3.13, p=0.04). There was no significant association between HPA-1, HPA-2, HPA-4, HPA-5, glycoprotein Ib-5 T/C as well as Ia G873A polymorphisms and increased risk of ischemic stroke.Conclusions We found that glycoprotein Ia C807T T allele or the TT genotype, the Ser-allele of HPA-3 and B allele of glycoprotein Ib variable number tandem repeat polymorphisms were associated with increased risk for ischemic stroke. Future studies with larger sample sizes will be necessary to confirm the results. In addition, analyses of ischemic stroke subtypes and gene-gene and gene-environment interactions are warranted.

Correlation Between Platelet Glycoprotein M a Gene Polymorphism and the Risk of Vascular Events in Patients Taking Aspirin after Intracranial and Extracranial Artery Stenting: a Prospective Case Series Study

Association of miR-146a rs2910164 and miR-499 rs3746444 polymorphisms with risk of ischemic stroke

Correlations of P2Y1 and ITGB3 Polymorphisms with Aspirin Resistance in Patients with Large Artery Atherosclerotic Stroke

Platelet Glycoprotein Gene Ia C807t, Hpa-3, And Ib Vntr Polymorphisms Are Associated With Increased Ischemic Stroke Risk: Evidence From A Comprehensive Meta-Analysis

Candidate Gene and Pathway Analyses Identifying Genetic Variations Associated with Prasugrel Pharmacokinetics and Pharmacodynamics.

Gene Polymorphism of Platelet Glycoprotein I Bα in Chinese Patients with Large- and Small-Artery Subtypes of Ischemic Stroke

Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Long-Term Cerebrovascular Outcomes in Patients With Minor Stroke or Transient Ischemic Attack

Relationship between cytochrome P450 2C19 polymorphisms and clinical outcomes in clopidogreltreated patients who underwent cerebrovascular stenting placement

Correlation study of gene polymorphism of CYP2 C19 and clopidogrel response after percutaneous translu-minal angioplasty and stenting in patients with ischemic cerebrovascular disease

Association between CYP2C19 polymorphisms and clinical outcomes in patients undergoing stent procedure for cerebral artery stenosis

Effect of PEAR1, PTGS1 gene polymorphisms on the recurrence of aspirin-treated patients with ischemic stroke in the Han population of China: A 4-year follow-up study

The efficacy and safety of aspirin-ticagrelor vs. aspirin-clopidogrel in ischemic stroke patients with cerebral artery stenting

High-on-treatment platelet reactivity predicts adverse outcome after carotid artery stenting: A prospective study

Impacts of COX-1 Gene Polymorphisms on Vascular Outcomes in Patients with Ischemic Stroke and Treated with Aspirin

The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation.

A Quantitative Assessment of the Association Between 1425G/A Polymorphism in PRKCH and Risk of Stroke

Association of ABCB1 promoter methylation with aspirin exposure, platelet function, and clinical outcomes in Chinese intracranial artery stenosis patients

Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response

Effects of CYP2C19 and ABCB1 Gene Polymorphisms on Anti-Platelet Function of Clopidogrel and Recurrent Vascular Events in Patients with Acute Ischemic Stroke

Candidate Gene of NOS3, MMP3, AGT, and AGT1R and Pathway Analyses for Platelet Reactivity and Clinical Outcomes of Repeat Revascularization After First PCI in Chinese Patients

Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention